CoChat

Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4

Open access
Kolb, Ryan, Kluz, Paige, Tan, Zhen Wei, Borcherding, Nicholas, Bormann, Nicholas, Vishwakarma, Ajaykumar, Balcziak, Louis, Zhu, Pengcheng, Davies, Brandon SJ., Gourronc, Francoise, Liu, Ling-Zhi, Ge, Xin, Jiang, Bing-Hua, Gibson-Corley, Katherine, Klingelhutz, Aloysius, Tan, Nguan Soon, Zhu, Yuwen, Sutterwala, Fayyaz S., Shen, Xian, Zhang, Weizhou · 2019 · Oncogene
Cited by 123

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Obesity is a risk factor for breast cancer and also predicts poor clinical outcomes regardless of menopausal status. Contributing to the poor clinical outcomes is the suboptimal efficacy of standard therapies due to dose limiting toxicities and obesity-related complications, highlighting the need to develop novel therapeutic approaches for treating obese patients. We recently found that obesity leads to an increase in tumor-infiltrating macrophages with activated NLRC4 inflammasome and increased interleukin (IL)−1β production. IL-1β, in turn, leads to increased angiogenesis and cancer progression. Using Next Generation RNA sequencing, we identified an NLRC4/IL-1β-dependent upregulation of angiopoietin-like 4 (ANGPTL4), a known angiogenic factor in cancer, in tumors from obese mice. ANGPTL4-deficiency by genetic knockout or treatment with a neutralizing antibody led to a significant reduction in obesity-induced angiogenesis and tumor growth. At a mechanistic level, ANGPTL4 expression is induced by IL-1β from primary adipocytes in a manner dependent on NF-κB- and MAP kinase-activation, which is further enhanced by hypoxia. This report shows that adipocyte-derived ANGPTL4 drives disease progression under obese conditions and is a potential therapeutic target for treating obese breast cancer patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41388-018-0592-6

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 123

Metadata

Authors
Kolb, R., Kluz, P., Tan, Z. W., Borcherding, N., Bormann, N., Vishwakarma, A., Balcziak, L., Zhu, P., Davies, B. S., Gourronc, F., Liu, L.-Z., Ge, X., Jiang, B.-H., Gibson-Corley, K., Klingelhutz, A., Tan, N. S., Zhu, Y., Sutterwala, F. S., Shen, X., & Zhang, W.
Venue
Oncogene
Published
2018-12-05
Volume
38
Issue
13
Pages
2351-2363
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W2902192147
Cited by
123
References
10
FWCI
3.53
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4. https://app.cochat.ai/papers/10.1038/s41388-018-0592-6
The paper
Kolb, R., Kluz, P., Tan, Z. W., Borcherding, N., Bormann, N., Vishwakarma, A., Balcziak, L., Zhu, P., Davies, B. S., Gourronc, F., Liu, L.-Z., Ge, X., Jiang, B.-H., Gibson-Corley, K., Klingelhutz, A., Tan, N. S., Zhu, Y., Sutterwala, F. S., Shen, X., & Zhang, W. (2019). Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4. Oncogene. https://doi.org/10.1038/s41388-018-0592-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.